Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Genentech | Researchclopedia

Back to institutions

Genentech

San Franciscocompany

935

Works

426,851

Citations

329

h-index

Top Research Topics

Monoclonal and Polyclonal Antibodies Research Protein purification and stability Viral Infectious Diseases and Gene Expression in Insects

Top Researchers

Jian Wu Ningbo University

11,168 works226,692 citationsh-index: 177

Recent Research

PO:05:136 Measurement of kidney disease in a novel treatment response measure for systemic lupus erythematosus clinical trials

Kathryn Connelly,Eric F Morand,et al.

20260 citations

HER2/EGFR in Cancer Research

Glycosylation and Glycoproteins Research

Angiogenesis and VEGF in Cancer

T-cell and B-cell Immunology

Cell Adhesion Molecules Research

Immune Cell Function and Interaction

Immune Response and Inflammation

Cytokine Signaling Pathways and Interactions

Cell death mechanisms and regulation

Aviv Regev Broad Institute

964 works224,374 citationsh-index: 208

David Botstein San Francisco VA Medical Center

534 works222,528 citationsh-index: 167

Carlos M. Duarte Centro de Investigação em Artes e Comunicação

1,751 works146,259 citationsh-index: 177

Napoleone Ferrara University of California, San Diego

389 works126,294 citationsh-index: 156

Joseph Schlessinger Yale University

719 works124,493 citationsh-index: 174

Bcl-xL interaction with VDAC1 reduces mitochondrial Ca <sup>2+</sup> uptake, allowing the establishment of Therapy-Induced Senescence

Andrea Puebla-Huerta,Pablo Morgado-Cáceres,et al.

20250 citations

Economic and clinical impact of emicizumab in people with moderate and severe Hemophilia A in the US

Janet Lee,Fadoua El Moustaid,et al.

20250 citations

Real-world treatment patterns for Hemophilia A since the launch of emicizumab in the US

Janet Lee,Robert Schuldt,et al.

20250 citations

Estimated total cost of care and patient out-of-pocket cost savings with first-line fixed duration venetoclax + obinutuzumab compared with treat-to-progression BTKi regimens among Medicare-eligible patients with chronic lymphocytic leukemia in the United States following the Inflation Reduction Act.

Sophia Li,Katherine Rosettie,et al.

20250 citations

Long-term immune reconstitution and final 1-year follow-up after fixed-duration venetoclax-obinutuzumab (VenO) in first-line (1L) chronic lymphocytic leukemia (CLL): Results from the Phase III CRISTALLO trial

Hyun Yong Jin,Jeff P. Sharman,et al.

20250 citations